Back to search

Spain· ES:52255

DOLCOPIN 1 g POLVO PARA SUSPENSION ORAL

A medicinal product containing almasilato, registered in Spain by Meda Pharma S.L..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedDOLCOPIN 1 g POLVO PARA SUSPENSION OR…ATC—REGISTER NO.ES:52255PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
almasilato
Manufacturer
Meda Pharma S.L.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Almasilato in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All almasilato products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Megalac, Megalac Mint

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/898b0935-6ad0-443f-aa60-ca757d575871
GET /v1/drugs/898b0935-6ad0-443f-aa60-ca757d575871?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Sin Receta",
  "estado": "{\"aut\":131324400000,\"rev\":1713448983000}",
  "nregistro": "52255",
  "substance": "almasilato"
}

See everything about almasilato.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.